Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Pablo González-Bustos"'
Autor:
Ricardo Roa-Chamorro, José Manuel Puerta-Puerta, Lucía Torres-Quintero, Fernando Jaén-Águila, Pablo González-Bustos, Miguel Ángel Rodríguez-Gil, Juan Diego Mediavilla-García
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Dyslipidemia is a frequent side effect associated with nilotinib treatment. Patients with chronic myeloid leukemia (CML) under treatment with nilotinib who develop dyslipidemia have been shown to have a higher risk of presenting atherosclero
Externí odkaz:
https://doaj.org/article/6820c6d5e24b4d3cba0ec2f2c4864085
Autor:
Ricardo Roa-Chamorro, Fernando Jaén-Águila, José Manuel Puerta-Puerta, Lucía Torres-Quintero, Pablo González-Bustos, Juan Diego Mediavilla-García
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Treatment of chronic myeloid leukaemia (CML) is based on tyrosine kinase inhibitors (TKI), whose introduction in 2001 improved the survival rate after 5 years from 40 to 90%. The longevity increase has been accompanied by a higher incidence
Externí odkaz:
https://doaj.org/article/f027b0237aed45dd809a0b10112f4dd8
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 34:285-290
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee90f50c592b741be1fa30bf9f62411
https://doi.org/10.1016/j.arteri.2022.06.003
https://doi.org/10.1016/j.arteri.2022.06.003
Autor:
Lucía Torres-Quintero, Juan Diego Mediavilla-García, Pablo González-Bustos, Ricardo Roa-Chamorro, José Manuel Puerta-Puerta, Fernando Jaén-Águila
Publikováno v:
Endocrinología, Diabetes y Nutrición. 69:446-450
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2668b5fe7881ddfff6ef39ff7dae24c7
https://doi.org/10.1016/j.endinu.2021.03.007
https://doi.org/10.1016/j.endinu.2021.03.007
Autor:
Mónica Zamora‐Pasadas, Rafael Marfil‐Álvarez, Pablo González‐Bustos, Antonio Magán‐Fernández, Francisco Mesa
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
instname
We would like to thank the patients from the Unit of Autoimmune Diseases of the “Virgen de las Nieves” University Hospital. This investigation has not received funds from any private entity. All procedures in this were performed from the regular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6eda27827febcb96b802c4e67451c9
https://doi.org/10.1111/jre.12977
https://doi.org/10.1111/jre.12977
Autor:
Antonio Gallo, Leopoldo Pérez de Isla, Sybil Charrière, Alexandre Vimont, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José L. Díaz-Díaz, Daniel Zambón, Philippe Moulin, Eric Bruckert, Pedro Mata, Sophie Béliard, Denis Angoulvant, Sophie Beliard, Franck Boccara, Bertrand Cariou, Valérie Carreau, Alain Carrie, Sybil Charrieres, Yves Cottin, Mathilde Di Filippo, Pierre Henri Ducluzeau, Sonia Dulong, Vincent Durlach, Michel Farnier, Emile Ferrari, Dorota Ferrieres, Jean Ferrieres, Philippe Giral, Sophie Gonbert, Regis Hankard, Jocelyn Inamo, Olga Kalmykova, Michel Krempf, Julie Lemale, François Paillard, Noel Peretti, Agnes Perrin, Alain Pradignac, Jean Pierre Rabes, Vincent Rigalleau, François Schiele, Ariane Sultan, Patrick Tounian, René Valero, Bruno Verges, Cecile Yelnik, Olivier Ziegler, Rocío Aguado, Ma Pilar Álvarez-Baños, Rosa Argüeso, Francisco Arrieta, Miguel Ángel Barba, Marta Casañas, José María Cepeda, Raimundo De Andrés, Gonzalo Díaz-Soto, Jose Luis Díaz-Diaz, Marta Dieguez, Ceferino Faedo, Francisco Fuentes, Juan A. Garrido, Aurora González, Pablo González-Bustos, Ma Dolores Mañas, Marta Mauri, Juan Diego Mediavilla, Alfredo Michán, Pablo Miramontes, Ovidio Muñiz, Leire Pérez, Leopoldo Perez De Isla, Xavier Pintó, Manuel J. Romero, Patricia Rubio, Juan F. Sánchez Muñoz-Torrero, Jose I. Vidal-Pardo
Publikováno v:
JACC: Cardiovascular Imaging
JACC: Cardiovascular Imaging, Elsevier/American College of Cardiology, 2021, ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, 2021, 14 (12), pp.2414-2424. ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, Elsevier/American College of Cardiology, 2021, ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, 2021, 14 (12), pp.2414-2424. ⟨10.1016/j.jcmg.2021.06.011⟩
International audience; ObjectivesThis study aimed at investigating the additional contribution of coronary artery calcium (CAC) score to SAFEHEART (Spanish Familial Hypercholesterolemia Cohort Study) risk equation (SAFEHEART-RE) for cardiovascular r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792b88d656c760f4d97dfef1bcb93ecf
https://doi.org/10.1016/j.jcmg.2021.06.011
https://doi.org/10.1016/j.jcmg.2021.06.011
Autor:
Rodrigo Milán Pinilla, María Magdalena Carrillo Bailén, Marina Blanco-Ruiz, María Josefa Álvarez Soria, Belén Sánchez Rodríguez, Patricia Martínez-Sánchez, Laura Amaya-Pascasio, Roberto Valverde Moyano, Irene Pérez Ortega, María Victoria Mejías Olmedo, Pablo González Bustos, Javier Fernández Pérez, Purificación Sánchez López, Reyes de Torres Chacón, Eduardo Agüera Morales, Manuel Payán Ortiz, Luis Andrade Zumárraga, Antonio Arjona-Padillo, Alba María Castillo Fernández, Cristina Del Toro Pérez, Beatriz Hidalgo Martín, Ricardo Roa Chamorro
Publikováno v:
Atherosclerosis Plus, Vol 45, Iss, Pp 32-38 (2021)
Background and aims: The benefits of the PCSK9 inhibitors, alirocumab and evolocumab, in lowering LDL-cholesterol and preventing major adverse cardiac events (MACE) have been demonstrated in pivotal clinical trials. However, few studies of routine cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2169b116cf8566849cf4241055ffa2d5
http://www.sciencedirect.com/science/article/pii/S2667089521000419
http://www.sciencedirect.com/science/article/pii/S2667089521000419
Publikováno v:
Hipertensión y Riesgo Vascular. 38:151-155
Survival of neoplasms has improved significantly in recent years. An increase in the incidence of cardiovascular disease has been observed. This is due to increasing age of patients and the side effects of chemotherapy. Anti-angiogenic drugs frequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::334c142e6814bf67cfece09424bd8f0b
https://doi.org/10.1016/j.hipert.2021.02.003
https://doi.org/10.1016/j.hipert.2021.02.003
Autor:
Ricardo Roa-Chamorro, José M. Puerta-Puerta, Lucía Torres-Quintero, Pablo González-Bustos, Fernando Jaén-Águila, Juan D. Mediavilla-García
Publikováno v:
Revista Sangre. 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::439179d3f13e93765a486506b34c96fa
https://doi.org/10.24875/sangre.22000002
https://doi.org/10.24875/sangre.22000002
Autor:
Ricardo Roa-Chamorro, José M. Puerta-Puerta, Lucía Torres-Quintero, Pablo González-Bustos, Fernando Jaén-Águila, Juan D. Mediavilla-García
Publikováno v:
Revista Sangre (ENG). 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::199533dec5a21bddb157cd5d9bd92e29
https://doi.org/10.24875/sangree.m22000002
https://doi.org/10.24875/sangree.m22000002